Cyclic peptides and disulfide bonds

Cyclization constrains a peptide's shape and can increase stability and receptor selectivity. This guide compares disulfide bridges, lactam bridges and head-to-tail cyclization, with examples such as oxytocin, PT-141, melanotan II and setmelanotide.

Last reviewed 2026-10-25 by the PeptideWiki editorial team. Editorial policy.

Why cyclize a peptide

A linear peptide in solution samples many conformations, only a few of which may fit a given receptor. Linking two parts of the chain covalently restricts this flexibility, holding the molecule closer to a defined shape. In many peptide series this improves affinity or selectivity for a target, although the effect is not guaranteed and depends on choosing a constraint compatible with the bioactive conformation.

Cyclization also tends to improve resistance to proteases. Exopeptidases need a free terminus, which head-to-tail cyclic peptides lack, and many endopeptidases require a flexible, extended backbone that a ring does not readily provide. Natural cyclic and disulfide-rich peptides, such as conotoxins and plant cyclotides, are studied partly for this reason.

Types of cyclization

Rings can be formed between almost any pair of reactive groups in a peptide. The main categories differ in chemistry, stability and how they are written; see peptide nomenclature and modifications.

• Disulfide bridge: an S–S bond between two cysteine side chains, or between cysteine and a related thiol residue such as penicillamine.
• Lactam bridge: an amide bond between an acidic side chain (Asp or Glu) and a basic one (Lys, Orn or another amine).
• Head-to-tail: an amide bond between the N-terminal amine and the C-terminal carboxyl, removing both termini.
• Side chain to terminus: a bond between a side chain and one terminus.
• Other linkages: thioethers, hydrocarbon staples formed by ring-closing metathesis, and triazoles from click chemistry.

Disulfide bridges

Disulfide bonds form when two cysteine thiols are oxidized, losing two hydrogen atoms; the cyclic form is therefore 2 Da lighter than the reduced linear form. They are common in natural peptide hormones and toxins. Oxytocin is a classic example: a nine-residue amidated peptide with a disulfide between Cys1 and Cys6 forming a six-residue ring with a short tail. Vasopressin shares the same architecture. Setmelanotide uses a disulfide to close a ring around the core melanocortin pharmacophore, with D-residues inside the ring.

Disulfides are reversible. Reducing agents such as dithiothreitol or tris(2-carboxyethyl)phosphine break them, and at neutral to basic pH free thiols can exchange with existing disulfides, scrambling the pairing or forming intermolecular dimers. Peptides with two or more disulfides can adopt several isomers of identical mass with different activity, so the correct connectivity must be confirmed, for example by partial reduction, enzymatic mapping or comparison with a reference standard.

Insulin, with three disulfides linking and stabilizing its two chains, and many venom-derived peptides with several interlocking disulfides show how these bonds can define a compact, folded architecture in molecules that are otherwise too short to fold stably. In such cases the disulfide pattern is part of the identity of the molecule, and a sample with scrambled pairing is effectively a different compound even though its sequence and mass are unchanged. Analytical documentation for multi-disulfide peptides should therefore address connectivity, not only mass and purity.

Lactam bridges

Lactam bridges form an amide bond between side chains, which is chemically more robust than a disulfide and is not affected by reducing conditions or thiol exchange. The ring size is tuned by the choice of residues and their spacing. Lactam bridges between positions i and i+4 are a common way to stabilize helices in peptide design.

Melanotan II and PT-141 (bremelanotide) are cyclic heptapeptides built on the same lactam ring, closed between an aspartic acid and a lysine side chain and containing the melanocortin core His-D-Phe-Arg-Trp. They differ at the C-terminus: melanotan II is a C-terminal amide, while bremelanotide carries a free carboxylic acid. That one difference changes the mass by about 1 Da and makes them distinct compounds, which is worth checking on any certificate of analysis.

Because lactams are formed by an ordinary amide bond, they are not reversed under the conditions used in most assays or storage. The trade-off is synthetic: forming the lactam requires protecting groups on the two side chains that can be removed selectively while the rest of the peptide remains protected, adding steps and potential side reactions. Lactam ring size and position can also be varied systematically, which has made this chemistry a common tool in structure-activity studies of melanocortin and other peptide ligands.

Head-to-tail and other cyclizations

Head-to-tail cyclic peptides have no free termini and often show marked protease resistance. Cyclosporine, a cyclic undecapeptide containing several N-methylated residues, is a well-known example among approved drugs and is notable for its unusual membrane permeability. Gramicidin S and many cyclic antimicrobial peptides are also head-to-tail cyclic.

More recent constraint strategies include hydrocarbon stapling, which links two non-natural olefin-bearing residues to lock a helix, and bicyclic peptides that use small chemical scaffolds to form two rings at once. These are largely research and development tools, and each creates a distinct molecule whose properties must be established individually.

Synthesis and analytical considerations

Cyclic peptides are usually assembled as linear precursors by solid-phase peptide synthesis and cyclized on the resin or in solution. Disulfides are formed by controlled oxidation, often at high dilution to favor intramolecular rings over dimers. Lactams require orthogonal side-chain protection so that only the intended groups react. Incomplete cyclization, dimers and cyclic oligomers are characteristic impurities.

In analysis, cyclic and linear forms differ in mass by known amounts: 2 Da for a disulfide and 18 Da for a lactam or head-to-tail amide, since water is lost on ring closure. They usually differ in HPLC retention as well. Dimers appear at twice the monomer mass minus the bridging atoms, and multiply charged ESI ions of a dimer can overlap with monomer peaks, so careful deconvolution is needed. See HPLC and mass spec explained.

Handling cyclic peptides

Disulfide-containing peptides should be protected from reducing agents and from basic conditions that promote thiol exchange; assay buffers containing dithiothreitol or other reductants will open the ring. Lactam-bridged peptides are generally more robust but still subject to the usual oxidation and deamidation pathways at susceptible residues.

Because cyclization removes charged termini in some designs and constrains conformation, solubility can differ from the linear analogue. The usual approach of estimating charge and hydrophobicity still applies; see solubility by sequence. Storage follows standard practice described in peptide storage and stability.

Frequently asked questions

Compounds mentioned

• Oxytocin
• PT-141 (bremelanotide)
• Melanotan II
• Setmelanotide